A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea

Research output: Contribution to journalComment/debateResearch

Standard

A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. / Gottlieb, Lisa A.

In: Journal of Cardiovascular Pharmacology, Vol. 84, No. 1, 2024, p. 32-33.

Research output: Contribution to journalComment/debateResearch

Harvard

Gottlieb, LA 2024, 'A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea', Journal of Cardiovascular Pharmacology, vol. 84, no. 1, pp. 32-33. https://doi.org/10.1097/FJC.0000000000001527

APA

Gottlieb, L. A. (2024). A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. Journal of Cardiovascular Pharmacology, 84(1), 32-33. https://doi.org/10.1097/FJC.0000000000001527

Vancouver

Gottlieb LA. A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. Journal of Cardiovascular Pharmacology. 2024;84(1):32-33. https://doi.org/10.1097/FJC.0000000000001527

Author

Gottlieb, Lisa A. / A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. In: Journal of Cardiovascular Pharmacology. 2024 ; Vol. 84, No. 1. pp. 32-33.

Bibtex

@article{f30050a95ba0443982131b461aaca88d,
title = "A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea",
author = "Gottlieb, {Lisa A}",
year = "2024",
doi = "10.1097/FJC.0000000000001527",
language = "English",
volume = "84",
pages = "32--33",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams & Wilkins",
number = "1",

}

RIS

TY - JOUR

T1 - A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea

AU - Gottlieb, Lisa A

PY - 2024

Y1 - 2024

U2 - 10.1097/FJC.0000000000001527

DO - 10.1097/FJC.0000000000001527

M3 - Comment/debate

C2 - 38086080

VL - 84

SP - 32

EP - 33

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 1

ER -

ID: 396849518